We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Proposes Banning High-Risk Cattle Materials in Medical Products
FDA Proposes Banning High-Risk Cattle Materials in Medical Products
February 15, 2007
The FDA wants to prohibit certain cattle materials from drugs, biologics and medical devices to lower the risk of bovine spongiform encephalopathy (BSE or mad cow disease).
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor